Biodistribution of methotrexate-monoclonal antibody conjugates and complexes: experimental and clinical studies
- 31 December 1987
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 14 (3-4) , 411-420
- https://doi.org/10.1016/0305-7372(87)90039-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibodyCancer Immunology, Immunotherapy, 1987
- Physical approach for the reduction of dual radionuclide image subtraction artefacts in immunoscintigraphyNuclear Medicine Communications, 1984
- The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumoursBritish Journal of Surgery, 1984
- Monoclonal antibodies to the chemotherapeutic agent methotrexate: Production, properties and comparison with polyclonal antibodiesJournal of Immunological Methods, 1984
- Hybrid hybridomas and their use in immunohistochemistryNature, 1983
- Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitroInternational Journal of Cancer, 1983
- Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancerBritish Journal of Cancer, 1983
- In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenograftsInternational Journal of Cancer, 1982
- Preparation of 125iodine-labelled methotrexate and its use in a magnetisable particle solid-phase radioimmunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Development and application of a radioimmunoassay for methotrexateBritish Journal of Cancer, 1977